This inventor holds 1 USPTO granted patent. Top assignee: University of Saskatchewan. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Yeun-Kyung Shin: Innovator in Influenza Research
Introduction
Yeun-Kyung Shin is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of influenza research, particularly through his innovative patent work. His research focuses on developing attenuated influenza virus variants that can enhance immune responses and provide new avenues for treatment and prevention.
Latest Patents
Yeun-Kyung Shin holds a patent for "Attenuated influenza NS1 variants." This patent describes attenuated influenza virus variants that include substitutions in the NS1 protein, which interfere with viral replication and phosphatidylinositol 3-kinase activation. The patent encompasses NS1 variant polypeptides, polynucleotides encoding these polypeptides, and a reverse genetics system for producing the attenuated variants. Additionally, it outlines immunogenic compositions that comprise live attenuated influenza virus NS1 variants, methods for stimulating immune responses against the influenza virus, and strategies for treating and preventing influenza virus infections.
Career Highlights
Yeun-Kyung Shin is affiliated with the University of Saskatchewan, where he conducts his research and development activities. His work has been instrumental in advancing the understanding of influenza virus mechanisms and potential therapeutic approaches.
Collaborations
Some of his notable coworkers include Yan Zhou and Lorne A Babiuk, who have collaborated with him on various research projects related to influenza.
Conclusion
Yeun-Kyung Shin's innovative work in the field of influenza research highlights his commitment to advancing medical science and improving public health. His contributions through patents and collaborations continue to pave the way for new treatments and preventive measures against influenza virus infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
